Severe adverse reaction risks during mass treatment with ivermectin in loiasis-endemic areas
Severe adverse reaction risks during mass treatment with ivermectin in loiasis-endemic areas
复制标题
DOI：
10.1016/0169-4758(96)40006-0
复制
发表时间：
1996-11-01
期刊：
影响因子：
--
通讯作者：
Ernould, JC
中科院分区：
文献类型：
--
作者：
Chippaux, JP;Boussinesq, M;Ernould, JC
控制盘尾丝虫病仍然是撒哈拉以南非洲的一个优先事项。Jean-Philippe Chippaux、Michel Boussinesq、Jacques Gardon、Nathalie Gardon-Wendel和Jean-Christophe Ernould在此概述了关于伊维菌素可能引起的严重不良反应的研究，伊维菌素用于控制盘尾丝虫病，在盘尾丝虫病也流行的地区，并讨论了在实施此类方案期间可能建议的预防措施。
The control of onchocerciasis remains a priority in sub-Saharan Africa. Jean-Philippe Chippaux, Michel Boussinesq, Jacques Gardon, Nathalie Gardon-Wendel and Jean-Christophe Ernould here outline studies concerning possible severe adverse reactions to ivermectin used to control onchocerciasis in areas where loiasis is also endemic, and discuss precautions that may be advisable during the implementation of such programmes.